Department of Physiology, Zhongshan School of Medicine, Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China.
Department of Biomedical Engineering, Xinhua College, Sun Yat‑sen University, Guangzhou, Guangdong 510520, P.R. China.
Mol Med Rep. 2017 Dec;16(6):8253-8258. doi: 10.3892/mmr.2017.7601. Epub 2017 Sep 25.
A previous study from our group has demonstrated that hydrogen administration can attenuate cardiovascular hypertrophy in vivo by targeting reactive oxygen species‑dependent mitogen‑activated protein kinase signaling. The aim of the present study is to determine the effect of hydrogen on cardiomyocyte autophagy during β‑adrenoceptor activation in vivo and in vitro. We prepared hydrogen‑rich medium, and the concentration of hydrogen was measured by using the MB‑Pt reagent method. For the in vitro study, H9c2 cardiomyocytes were stimulated with isoproterenol (ISO; 10 µM) for 5, 15 and 30 min, and then the protein expression levels of the autophagy marker microtubule‑associated protein 1 light chain 3β II (LC3B II) were examined by western blotting. The effect of hydrogen‑rich medium was then tested by pretreating the H9c2 cardiomyocytes with hydrogen‑rich medium for 30 min, then stimulating with ISO, and examining the protein expression levels of the autophagy marker LC3B II. For the in vivo study, mice received hydrogen (1 ml/100 g/day, by intraperitoneal injection) for 7 days prior to ISO administration (0.5 mg/100 g/day, by subcutaneous injection), and subsequently received hydrogen with or without ISO for another 7 days. Hypertrophic responses were examined by heart weight (HW) and heart weight/body weight (HW/BW) measurements. The protein expression of autophagy markers Beclin1, autophagy‑related protein 7 (Atg7) and LC3B II were examined. The results demonstrated that excessive autophagy occurred following 5 min of ISO stimulation in vitro. This enhanced autophagy was blocked by pretreatment with hydrogen‑rich medium. Furthermore, hydrogen improved the deteriorated hypertrophic responses and inhibited the enhanced autophagic activity mediated by ISO administration in vivo, as indicated by decreasing HW and HW/BW, and suppressing the protein expression levels of Beclin1, Atg7 and LC3B II. Therefore, the results of the present study demonstrated that hydrogen inhibited ISO‑induced excessive autophagy in cardiomyocyte hypertrophy models in vitro and in vivo.
先前我们的研究小组已经证明,氢气治疗可以通过靶向活性氧依赖性丝裂原激活蛋白激酶信号来减轻体内心血管肥大。本研究旨在确定氢气对体内和体外β-肾上腺素能受体激活时心肌细胞自噬的影响。我们制备了富氢培养基,并使用 MB-Pt 试剂法测量了氢气浓度。在体外研究中,用异丙肾上腺素(ISO;10 μM)刺激 H9c2 心肌细胞 5、15 和 30 min,然后通过 Western blot 检测自噬标志物微管相关蛋白 1 轻链 3β II(LC3B II)的蛋白表达水平。然后通过用富氢培养基预处理 H9c2 心肌细胞 30 min,再用 ISO 刺激,检测自噬标志物 LC3B II 的蛋白表达水平,测试富氢培养基的作用。在体内研究中,在 ISO 给药(皮下注射 0.5 mg/100 g/天)前,小鼠腹腔注射氢气(1 ml/100 g/天)7 天,然后再用或不用 ISO 接受氢气 7 天。通过心脏重量(HW)和心脏重量/体重(HW/BW)测量来检查肥大反应。检查自噬标志物 Beclin1、自噬相关蛋白 7(Atg7)和 LC3B II 的蛋白表达。结果表明,体外 ISO 刺激 5 min 后发生过度自噬。这种增强的自噬被富氢培养基预处理所阻断。此外,氢气改善了 ISO 给药引起的体内恶化的肥大反应,并抑制了 ISO 介导的增强的自噬活性,表现为 HW 和 HW/BW 降低,以及抑制 Beclin1、Atg7 和 LC3B II 的蛋白表达水平。因此,本研究的结果表明,氢气抑制了体内和体外心肌细胞肥大模型中 ISO 诱导的过度自噬。